Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
General anaesthesia compared to conscious sedation for catheter ablation of atrioventricular nodal reentrant tachycardia in adolescents
Session:
SESSÃO DE POSTERS 55 - ARRITMOLOGIA: NOVOS DESAFIOS
Speaker:
Pedro Mangas Palma
Congress:
CPC 2025
Topic:
C. Arrhythmias and Device Therapy
Theme:
06. Supraventricular Tachycardia (non-AF)
Subtheme:
06.4 Supraventricular Tachycardia (non-AF) - Treatment
Session Type:
Cartazes
FP Number:
---
Authors:
Pedro Miguel Mangas Neto da Palma; Miguel Rocha; Helena Moreira; Luís Santos; Cátia Oliveira; Ana Pinho; João Calvão; Ricardo Pinto; Marta Madeira; Gonçalo Pestana; Ana Lebreiro; Luís Adão
Abstract
<p><strong>Introduction</strong><br /> Atrioventricular nodal reentrant tachycardia (AVNRT) is one of the most common types of supraventricular tachycardia (SVT) in adolescents, with catheter ablation (CA) for slow pathway modification being the preferred treatment for symptomatic patients. For safety and comfort, ablation in paediatric patients is typically performed under general anaesthesia (GA). However, GA can contribute to prolonged procedural time and extended hospital stays. Alternatively, ablation under conscious sedation (CS) has been safely performed in adolescents, though data on its procedural and long-term outcomes remain limited.</p> <p><strong>Purpose</strong><br /> To characterise AVNRT ablation in adolescents and evaluate long-term outcomes and complications in ablations performed under CS compared to those under GA.</p> <p><strong>Methods</strong><br /> We conducted a single-centre retrospective cohort study, including all patients aged 12 to 18 who underwent CA for AVNRT between 2016 and 2023. Patients with congenital heart disease, severe comorbidities or accessory pathways were excluded.</p> <p><strong>Results</strong><br /> A total of 58 patients underwent CA during the assessment period, with a mean age of 15.3 ± 2.19 years. The median weight was 56 kg (IQR 17 kg), and 59% were female. SVT was documented in 90% of cases. Additionally, 84% of patients were on antiarrhythmic medication: 67% were receiving beta-blockers alone, 14% were on a combination of beta-blockers and flecainide, and 3% were on flecainide alone.<br /> All patients underwent radiofrequency CA. In 55% of the procedures, patients received GA, and an electroanatomic mapping was performed in 76% of cases. Typical AVNRT was observed in the majority of patients (98%).<br /> Patients in the GA group were younger (mean age 14.4 vs. 16.3 years, p < 0.001) and had a lower median weight (56 kg vs. 65 kg, p = 0.042). Procedure duration tended to be longer in the GA group (65 vs. 51 minutes, p = 0.058), although fluoroscopic time (0.8 vs. 0.6 minutes, p = 0.791) and radiation dose (32 vs. 27 µGym², p = 0.881) were similar between the groups.<br /> Over a median follow-up of 3.5 years, AVNRT recurrence rates (9.1% in the GA group and 6.3% in the CS group, p = 0.477) and repeat ablation rates (4.5% in the GA group and 6.3% in the CS group, p = 0.671) were similar. No major complications were observed; however, two cases of first-degree AV block occurred in the GA group, while none were reported in the CS group.</p> <p><strong>Conclusion</strong><br /> Our study suggests that AVNRT CA in adolescents can be effectively performed under CS, with high procedural success and a low risk of complications or recurrence.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site